LNAI
Lunai Bioworks Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.33
+2.42%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$2.27
From 52W high−83.36%
Volume16302.00
Market cap$10.56M
P/E (TTM)—
P/S (TTM)504.4x
Div yield—
Key dataSep 18, 2026
Open
$2.27
From 52W high
−83.36%
Volume
16302.00
Market cap
$10.56M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
P/E (TTM)
—
RSI (14)
46.7
MomentumView details →
1D Return
+2.42%
YTD Return
−67.94%
Similar companies
Latest newsMore news →
Lunai Bioworks' BioSymetrics subsidiary shared results from a technical case study supporting the development of structure-based screening tools for chemical outputs generated by large language models and other AI systems.4d agoLunai Bioworks filed a second amended complaint in its naked short selling lawsuit, adding six broker-dealers as defendants and alleging securities fraud and market manipulation under Rule 10b-5.24d agoLunai Bioworks filed an amended complaint in a lawsuit naming 10 defendants for naked short selling fraud, alleging 29.6 million failed-to-deliver shares and seeking treble damages under federal RICO statute.47d ago